.Nature Medication, Released online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medicine conjugate (ADC) tisotumab vedotin caused strengthened progression-free and also total survival, bring about FDA approval and a brand new therapy option for patients.